{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:58:37Z","timestamp":1778684317410,"version":"3.51.4"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.hoc.2005.08.004","type":"journal-article","created":{"date-parts":[[2005,11,7]],"date-time":"2005-11-07T10:44:29Z","timestamp":1131360269000},"page":"975-987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["New Therapies for Sickle Cell Disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Iheanyi E.","family":"Okpala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2005.08.004_bib1","first-page":"118","article-title":"Hereditary qualitative and quantitative erythrocyte defects in Ghana: an historical and geographical survey","volume":"7","author":"Konotey-Ahulu","year":"1968","journal-title":"Ghana Med J"},{"key":"10.1016\/j.hoc.2005.08.004_bib2","series-title":"The diseases of tropical climates and their treatment","author":"Horton","year":"1874"},{"key":"10.1016\/j.hoc.2005.08.004_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archinte.1910.00050330050003","article-title":"Peculiar elongated and sickled red blood corpuscles in a case of severe anaemia","volume":"6","author":"Herrick","year":"1910","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hoc.2005.08.004_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0037-1963(01)90023-X","article-title":"Pathophysiology of sickle cell disease: role of genetic and cellular modifiers","volume":"38","author":"Steinberg","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10245330400001926","article-title":"Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease","volume":"19","author":"Win","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.hoc.2005.08.004_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0268-960X(03)00037-7","article-title":"The intriguing contribution of white blood cells to sickle cell disease\u2013a red cell disorder","volume":"18","author":"Okpala","year":"2004","journal-title":"Blood Rev"},{"key":"10.1016\/j.hoc.2005.08.004_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.1989.tb24158.x","article-title":"The kidney, hepatobiliary system, and spleen in sickle cell anaemia","volume":"565","author":"Pearson","year":"1989","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.hoc.2005.08.004_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJM197304192881601","article-title":"An abnormality of the alternative pathway of complement activation in sickle cell disease","volume":"288","author":"Johnston","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.004_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1699-0463.1999.tb01463.x","article-title":"Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia","volume":"107","author":"Anyaegbu","year":"1999","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.hoc.2005.08.004_bib11","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1182\/blood.V91.9.3423","article-title":"Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease","volume":"91","author":"Mollapour","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0609.1998.tb01036.x","article-title":"Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia","volume":"60","author":"Anyaegbu","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.004_bib14","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease","volume":"340","author":"Steinberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.004_bib15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(71)90335-7","article-title":"Genetic neutropenia in people of African ancestry","volume":"2","author":"Shaper","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2005.08.004_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jcp.49.8.664","article-title":"Ethnic and sex differences in the total and differential white cell count and platelet count","volume":"49","author":"Bain","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.hoc.2005.08.004_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0950-3536(11)80026-0","article-title":"Platelets and platelet disorders in Africa (review)","volume":"5","author":"Essien","year":"1992","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib18","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease\u2013life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.004_bib19","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1542\/peds.103.3.640","article-title":"Silent cerebral infarcts in sickle cell anemia: a risk factor analysis","volume":"103","author":"Kinney","year":"1999","journal-title":"Paediatrics"},{"key":"10.1016\/j.hoc.2005.08.004_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome of sickle cell disease: incidence and risk factors in the cooperative study of sickle cell disease","volume":"84","author":"Castro","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(05)60614-9","article-title":"Granulocytosis causing sickle cell crisis","volume":"351","author":"Abboud","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2005.08.004_bib23","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2005.08.004_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<148::AID-AJH12>3.0.CO;2-I","article-title":"Hydroxyurea use in pregnancy: a case report in sickle cell disease and review of the literature","volume":"60","author":"Diav-Citrin","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1592\/phco.19.18.1459.30901","article-title":"Hydroxyurea in two pregnant women with sickle cell anemia","volume":"19","author":"Byrd","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.hoc.2005.08.004_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/15287398209530252","article-title":"Comparison of teratogenic effects of aspirin and hydroxyurea in Fischer 344 and Wistar strains","volume":"10","author":"De Pass","year":"1982","journal-title":"J Toxicol Environ Health"},{"key":"10.1016\/j.hoc.2005.08.004_bib27","series-title":"Practical management of haemoglobinopathies","first-page":"162","article-title":"Assessment of severity and hydroxyurea therapy in sickle cell disease","author":"Okpala","year":"2004"},{"key":"10.1016\/j.hoc.2005.08.004_bib28","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phaseI\/II trial","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib29","series-title":"Management of sickle cell disease","first-page":"161","article-title":"Fetal hemoglobin induction","year":"2002"},{"key":"10.1016\/j.hoc.2005.08.004_bib30","first-page":"367","article-title":"Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease","volume":"36","author":"Triadou","year":"1994","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib31","first-page":"1411","article-title":"Are we underestimating the leukemogenic risk of hydroxyurea?","volume":"23","author":"Al Jam'a","year":"2002","journal-title":"Saudi Med J"},{"key":"10.1016\/j.hoc.2005.08.004_bib32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7326\/0003-4819-133-11-200012050-00029","article-title":"Acute leukaemia in a patient with sickle cell anemia treated with hydroxyurea","volume":"133","author":"Wilson","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2005.08.004_bib33","first-page":"415","article-title":"Leukaemogenesis of hydroxyurea in the treatment of sickle cell anemia","volume":"94","author":"Rauch","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/blood-2004-01-0322","article-title":"Mortality in sickle cell patients on hydroxyurea therapy","volume":"105","author":"Bakanay","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib35","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V95.11.3589","article-title":"Acquired DNA mutations associated with in vivo hydroxyurea exposure","volume":"95","author":"Hanft","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib36","first-page":"15","article-title":"Mechanisms of action of hydroxyurea in sickle cell anaemia in adults","volume":"34","author":"Charache","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200316672","article-title":"Hydroxyurea induces fetal hemoglobin by nitric-oxide dependent activation of soluble guanylyl cyclase","volume":"111","author":"Cokic","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2005.08.004_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1600-0609.2002.02775.x","article-title":"Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells","volume":"69","author":"Okpala","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib39","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood.V89.7.2554","article-title":"Decrease of very late activation antigen-4 and CD36 expression on reticulocytes in sickle cell patients treated with hydroxyurea","volume":"89","author":"Styles","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib40","first-page":"1790","article-title":"Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease","volume":"93","author":"Atweh","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib41","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2003-05-1738","article-title":"Effects of 5-aza-2\u2032-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic diffrentiation in patients with sickle cell disease","volume":"102","author":"Saunthararajah","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib42","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and thrombotic activity in sickle cell disease by dietary n-3 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hoc.2005.08.004_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1024\/0300-9831.69.2.83","article-title":"Plasma vitamins A and E in preterm babies fed on breast milk or formula milk with or without long-chain polyunsaturated fatty acids","volume":"69","author":"Ghebremeskel","year":"1999","journal-title":"Int J Nutr Res"},{"key":"10.1016\/j.hoc.2005.08.004_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11745-003-1065-1","article-title":"The potential role for arachidonic and docosahexanoic acids in protection against some central nervous system injuries in preterm infants","volume":"38","author":"Crawford","year":"2003","journal-title":"Lipids"},{"key":"10.1016\/j.hoc.2005.08.004_bib45","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1007\/BF02562227","article-title":"Evidence for the function of DHA during the evolution of the modern hominid brain","volume":"34","author":"Crawford","year":"1999","journal-title":"Lipids"},{"key":"10.1016\/j.hoc.2005.08.004_bib46","series-title":"Textbook of perinatal medicine","article-title":"The role of essential fatty acids and anti-oxidants in neuro-vascular development and complications of prematurity","author":"Ghebremeskel","year":"2005"},{"issue":"6","key":"10.1016\/j.hoc.2005.08.004_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.plefa.2005.03.005","article-title":"Steady state haemoglobin level in sickle cell anaemia increases with the proportion of erythrocyte membrane n-3 fatty acids","volume":"72","author":"Ren","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"9","key":"10.1016\/j.hoc.2005.08.004_bib48","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-005-1023-7","article-title":"Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease","volume":"84","author":"Ren","year":"2005","journal-title":"Ann Hematol"},{"issue":"Suppl","key":"10.1016\/j.hoc.2005.08.004_bib49","first-page":"970a","article-title":"Steady state haemoglobin level in sickle cell anaemia increases with the proportion of erythrocyte membrane n-3 fatty acids","volume":"104","author":"Okpala","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0891-5849(91)90156-W","article-title":"Increased n-3 polyunsaturated fatty acid content of red blood cells from fish oil-fed rabbits increases in vitro lipid peroxidation, but decreases hemolysis","volume":"11","author":"Van den Berg","year":"1991","journal-title":"Free Radic Biol"},{"key":"10.1016\/j.hoc.2005.08.004_bib51","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11745-003-1068-y","article-title":"N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic","volume":"38","author":"Calder","year":"2003","journal-title":"Lipids"},{"key":"10.1016\/j.hoc.2005.08.004_bib52","first-page":"43807","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J Biochem (Tokyo)"},{"key":"10.1016\/j.hoc.2005.08.004_bib53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/00007890-199612150-00020","article-title":"Docosahexaenoic and eicosapentanoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion","volume":"62","author":"Khalfoun","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.hoc.2005.08.004_bib54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","article-title":"Effects of changes in fat, fish and fibre intakes on death and myocardial infarction: diet and re-infarction trial (DART)","volume":"2","author":"Burr","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2005.08.004_bib55","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.1780370608","article-title":"Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. a 12-month, double-blind, controlled study","volume":"37","author":"Geusens","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.hoc.2005.08.004_bib56","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199606133342401","article-title":"Effect of enteric-coated fish-oil preparation on relapses in Crohn's disease","volume":"334","author":"Belluzi","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.004_bib57","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1172\/JCI117149","article-title":"Treatment with oral clotrimazole blocks Ca2 + -mediated K + transport and reverses erythrocyte dehydration in transgenic SAD mice: a model for therapy of sickle cell disease","volume":"93","author":"De Franceschi","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2005.08.004_bib58","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2002-05-1433","article-title":"ICA-17043 a novel Gardos channel blocker, prevents sickle red blood cell dehydration in vitro and in vivo in SAD mice","volume":"101","author":"Stocker","year":"2003","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.hoc.2005.08.004_bib59","first-page":"33a","article-title":"Efficacy and safety of the Gardos channel inhibitor, ICA-17043, in paients with sickle cell anemia","volume":"104","author":"Ataga","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib60","series-title":"Sickle cell disease: a handbook for the general clinician","first-page":"43","article-title":"The pathophysiology of sickle cell disease","author":"Attah","year":"1982"},{"key":"10.1016\/j.hoc.2005.08.004_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0268-960X(96)90018-1","article-title":"The pathophysiology of vascular obstruction in the sickle syndromes","volume":"10","author":"Kaul","year":"1996","journal-title":"Blood Rev"},{"key":"10.1016\/j.hoc.2005.08.004_bib62","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V95.2.368","article-title":"Monoclonal antibodies to \u03b1V\u03b23 (7E3 and LM609) inhibit sickle red blood cell-endothelial interactions induced by platelet-activating factor","volume":"95","author":"Kaul","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/jcp.44.6.459","article-title":"Patterns of mortality in sickle cell disease in the UK","volume":"44","author":"Gray","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.hoc.2005.08.004_bib64","series-title":"Practical management of haemoglobinopathies","first-page":"130","article-title":"Pulmonary hypertension: a complication of haemolytic states","author":"Okpala","year":"2004"},{"key":"10.1016\/j.hoc.2005.08.004_bib65","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0889-8588(05)70401-9","article-title":"Systemic fat embolism and pulmonary hypertension in sickle cell disease","volume":"10","author":"Castro","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.hoc.2005.08.004_bib66","series-title":"Abstracts from the National Sickle Cell Conference of USA (Washington [DC], September 17\u201323, 2002)","first-page":"54","article-title":"A clinical study of the efficacy of nitric oxide delivery via portable versus conventional systems to reduce secondary pulmonary hypertension in sickle cell anemia","author":"Coles","year":"2002"},{"issue":"Suppl","key":"10.1016\/j.hoc.2005.08.004_bib67","first-page":"452a","article-title":"Arginine therapy improves pulmonary artery pressures in patients with sickle cell disease and pulmonary hypertension","volume":"100","author":"Morris","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib68","series-title":"Abstracts from the 25th Meeting of the International Society of Haematology\u2014African & European Division (Durban [South Africa], September 18\u201323, 1999)","first-page":"120","article-title":"Pulmonary hypertension in sickle cell disease","author":"El-Beshlawy","year":"1999"},{"key":"10.1016\/j.hoc.2005.08.004_bib69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.08.004_bib70","series-title":"Practical management of haemoglobinopathies","first-page":"134","article-title":"Stroke in sickle cell disease","author":"Kwiatkowiski","year":"2004"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2005.08.004_bib71","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0037-1963(01)90055-1","article-title":"Indications for red cell transfusion in sickle cell disease","volume":"38","author":"Ohene-Frempong","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib72","series-title":"Education program book from the 46th Annual Meeting of American Society of Hematology (San Diego [CA], December 4\u20137, 2004)","first-page":"35","article-title":"Epidemiology and treatment of silent cerebral infarcts in sickle cell anemia","author":"DeBaun","year":"2004"},{"key":"10.1016\/j.hoc.2005.08.004_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","article-title":"Role of deferiprone in chelation therapy for transfusional iron overload","volume":"102","author":"Hoffbrand","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.08.004_bib74","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron levels and ventricular function in beta thalassaemia","volume":"360","author":"Anderson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2005.08.004_bib75","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2141.2000.01866.x","article-title":"Safety profile of the oral iron chelator deferiprone: a multicenter study","volume":"108","author":"Cohen","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2005.08.004_bib76","first-page":"565","article-title":"Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to \u03b2-thalassaemia","volume":"43","author":"Galanello","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.hoc.2005.08.004_bib77","first-page":"5a","article-title":"Phase II study of oral chelator ICL670 in thalassaemia patients with transfusional iron overload: efficacy, safety, pharmacokinetics and pharmacodynamics after 6 months of therapy","volume":"100","author":"Piga","year":"2002","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858805000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858805000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:38:18Z","timestamp":1760182698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858805000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0889858805000948"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2005.08.004","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Therapies for Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2005.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}